Short Interest in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Drops By 47.4%

Bullfrog AI Holdings, Inc. (NASDAQ:BFRGGet Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 286,000 shares, a drop of 47.4% from the February 28th total of 543,400 shares. Approximately 4.3% of the shares of the stock are short sold. Based on an average trading volume of 846,100 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Trading of Bullfrog AI

Several hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC raised its position in shares of Bullfrog AI by 31.0% during the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after buying an additional 11,140 shares during the period. Raymond James Financial Inc. acquired a new stake in Bullfrog AI during the fourth quarter worth $30,000. Finally, Two Sigma Securities LLC purchased a new stake in Bullfrog AI in the fourth quarter valued at $41,000. Hedge funds and other institutional investors own 0.96% of the company’s stock.

Bullfrog AI Stock Performance

Shares of BFRG opened at $1.81 on Friday. The stock has a 50 day moving average price of $2.38 and a 200 day moving average price of $2.38. Bullfrog AI has a one year low of $1.43 and a one year high of $4.84. The stock has a market capitalization of $17.04 million, a price-to-earnings ratio of -2.13 and a beta of 0.32.

Bullfrog AI (NASDAQ:BFRGGet Free Report) last released its quarterly earnings data on Friday, March 14th. The company reported ($0.18) EPS for the quarter.

Bullfrog AI Company Profile

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

See Also

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.